TIMOTHY TOBOLIC: Open Payments
NPI 1013940584 · BYRON CENTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $118 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| PFIZER INC. | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Amgen Inc. | 3 | $45 |
| Exact Sciences Corporation | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Seqirus USA Inc | 2 | $31 |
| Lilly USA, LLC | 1 | $14 |
Products named: TRELEGY ELLIPTA, OTEZLA, PREVNAR 20, Cologuard Collection Kit, AIRSUPRA, FARXIGA, CAPLYTA, Flucelvax.
Industry payments across MI — which companies pay providers there.
